All Resources
How Should We Monitor People with IAb Positivity?
Partha Kar talks to Sanjoy Dutta, CSO of Breakthrough T1D, about how to monitor people with IAb positivity.
The Importance of C-peptide in Autoimmune T1D
An infographic summarising C-peptide, a key biomarker of beta-cell function.
The Importance of Early T1D Detection
Learn about autoimmune type 1 diabetes (T1D) and the importance of early detection through islet autoantibody (IAb) screening.
.png/jcr:content/400x300_Early%20Identification%20The%20Role%20of%20C-peptide%20in%20the%20Diagnosisand%20Management%20of%20T1D%20(1).png)
Early Identification: The Role of C-peptide in the Diagnosis and Management of T1D
Expert interview highlighting the importance and role of C-peptide during the diagnosis and management of type 1 diabetes
ESPE-ESE 2025 Symposium Summary
At the BR1DGE symposium at ESPE-ESE 2025, experts discussed the benefits of early detection of people with presymptomatic type 1 diabetes (T1D) and the practical insights from ongoing T1D screening programs.
This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform.
Clear Communication is Essential to Convey the Benefits of T1D Screening
Clear communication about risks, disease stages, and early detection is a key component of successful T1D screening (Prof. Michael Haller).
Communicating Healthy Behaviors in T1D
Prof. Haller explains that educating caregivers of children with T1D is important so they understand progression risk and the benefits of lifestyle changes.
The Importance of Early T1D Detection
Prof. Danne explains that widespread implementation of early T1D detection provides a window of opportunity to prepare for and ameliorate the subsequent clinical impact.
Challenges in Diagnosis: Adult-Onset T1D versus T2D
Dr Jeremy Pettus highlights key challenges when identifying adult-onset T1D versus T2D, which can lead to frustration and ineffective management.
AI-powered Risk Stratification in Type 1 Diabetes
Dr Gun Forsander discusses how AI-powered risk stratification may be utilized to optimize T1D screening strategies
An Overview of Islet Autoantibody Tests
Dr Daniel Agardh discusses the multiple technologies now available for detecting islet autoantibodies associated with type 1 diabetes
T1D: Debunking the Age Myth
An infographic describing the prevalence of and challenges faced in diagnosing adult-onset T1D